Highlights | Tongrenxin Biotechnology's Successful Conclusion at the 2024 Chongqing CACLP
Release time:
2024-03-18
s
From March 16 to 18, 2024, the 22nd China International Expo on Laboratory Medicine and Blood Transfusion Instruments and Reagents (CACLP) was held at the Chongqing International Expo Center. After three days, the largest IVD event in the country came to a successful conclusion.
As one of the important raw material suppliers in the in vitro diagnostic industry, Tongrenxin Bio communicated and exchanged ideas with IVD companies from all over the country, showcasing core raw materials such as antigens, antibodies, and molecular diagnostic enzymes.
In the past year, Tongrenxin has been continuously developing and launching more products, covering new raw materials in series such as myocarditis, tumor markers, liver fibrosis, infectious diseases, and thyroid function, contributing to the in vitro diagnostic industry.
NEW PRODUCTS
At the exhibition site, the professional technicians of Tongrenxin Bio patiently, meticulously, and thoroughly explained the products to new and old customers who came for consultation.
In addition to domestic customers, the company's newly launched monoclonal antibodies, recombinant antigens, and immunochromatography large plates have also been favored by new and old customers abroad.
The three-day CACLP concluded successfully, and we thank all the customer partners who visited our booth for their recognition and trust. In the future, Tongrenxin Bio will continue to deepen its efforts in the in vitro diagnostic field, committed to product research and innovation, providing customers with higher quality, more cost-effective, and diversified products and services.
Related News